Therapeutics Targeting FGF Signaling Network in Human Diseases

Title
Therapeutics Targeting FGF Signaling Network in Human Diseases
Authors
Keywords
epithelial-to-mesenchymal transition, erdafitinib, infigratinib, immune-checkpoint blocker, miRNA, myeloproliferative syndrome.
Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 37, Issue 12, Pages 1081-1096
Publisher
Elsevier BV
Online
2016-10-27
DOI
10.1016/j.tips.2016.10.003

Ask authors/readers for more resources

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started